Frail and sarcopenia in diabetic patients
Conditions
Interventions
Diabetic nephropathy 1st, 2nd, 3rd: Meibalance Reha Support Mini (Meiji) Diabetic nephropathy 4th: Aminocare jelly leucine 40 (Nestle Health Science) Consume the above one everyday, in addition to e
Sponsors
Seiwakai Muta Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diabetes patients over 65 years old who are visiting Muta Hospital
Exclusion criteria
Exclusion criteria: 1: Those who are allergic to allergic indication components of nutritional supplements used in this study 2: Those who are extremely poor in general condition or those who are not permitted to exercise therapy from their doctor 3: Those who do not agree with this research 4: Persons who can not measure body composition with an inbody770 due to difficulty holding upright position
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Fraility Scale, Sarcopenia Evaluation factors(Grip strength, walking speed, muscle mass),Intervention period:3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| blood test (blood collection within the general diagnostic range such as HbA1c value and blood sugar level, high sensitivity CRP, 25 (OH) vitamin D, prealbumin, DHEAS, Zn, Cu), urinalysis items (general medical items, urinary albumin), nutrition survey, MNA-SF, MMSE, Vitality Index, GDS 15, medical records.There is possibility to add or refer to noninvasive inspection items other than the above. | — |
Countries
Japan
Contacts
Public ContactYuya Fujihara
Seiwakai Muta Hospital Internal medicine,Department of Diabetes Medicine
Outcome results
None listed